DANIELLE GREGOIRE: Open Payments
NPI 1639261977 · BRADFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 31 payments from 9 companies in 2025. Trend: 2023 $1,361 · 2024 $598 · 2025 $694
Food & beverage: $694
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $237 |
| Exact Sciences Corporation | 5 | $117 |
| Amgen Inc. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Lilly USA, LLC | 1 | $19 |
Products named: Ozempic, Cologuard Collection Kit, OTEZLA, FARXIGA, Wegovy, TRINTELLIX, GVOKE HYPOPEN, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
